Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.

Dominic Paul McGovernMark E McClureMatthew CoatesSimon BondMarcos Martinez Del PeroKim MynardJacinta LeeRona M SmithDavid R JayneMenna Ruth ClatworthyRachel B Jonesnull null

Published in: BMJ open (2024)

ISRCTN13069630.

Keyphrases

phase ii
clinical trial
double blind
placebo controlled
open label
phase iii
study protocol
chronic lymphocytic leukemia
diffuse large b cell lymphoma